1
|
Bhattacharjee D, Flores C, Woelfel-Monsivais C, Seekatz AM. Diversity and Prevalence of Clostridium innocuum in the Human Gut Microbiota. mSphere 2023; 8:e0056922. [PMID: 36541771 PMCID: PMC9942572 DOI: 10.1128/msphere.00569-22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Accepted: 11/22/2022] [Indexed: 12/24/2022] Open
Abstract
Clostridia are a polyphyletic group of Gram-positive, spore-forming anaerobes in the Firmicutes phylum that significantly impact metabolism and functioning of the human gastrointestinal tract. Recently, Clostridia were divided into two separate classes, Clostridia and Erysipelotrichia, based on phenotypic and 16S rRNA gene-based differences. While Clostridia include many well-known pathogenic bacteria, Erysipelotrichia remain relatively uncharacterized, particularly regarding their role as a pathogen versus commensal. Despite wide recognition as a commensal, the erysipelotrichial species Clostridium innocuum has recently been associated with various disease states. To further understand the ecological and potential virulent role of C. innocuum, we conducted a genomic comparison across 38 C. innocuum isolates and 194 publicly available genomes. Based on colony morphology, we isolated multiple C. innocuum cultivars from the feces of healthy human volunteers (n = 5). Comparison of the 16S rRNA gene of our isolates against publicly available microbiota data sets in healthy individuals suggests a high prevalence of C. innocuum across the human population (>80%). Analysis of single nucleotide polymorphisms (SNPs) across core genes and average nucleotide identify (ANI) revealed the presence of four clades among all available genomes (n = 232 total). Investigation of carbohydrate and protein utilization pathways, including comparison against the carbohydrate-activating enzyme (CAZyme) database, demonstrated inter- and intraclade differences that were further substantiated in vitro. Collectively, these data indicate genetic variance within the C. innocuum species that may help clarify its role in human disease and health. IMPORTANCE Clostridia are a group of medically important anaerobes as both commensals and pathogens. Recently, a new class of Erysipelotrichia containing a number of reassigned clostridial species has emerged, including Clostridium innocuum. Recent studies have implicated C. innocuum as a potential causative agent of diarrhea in patients from whom Clostridioides difficile could not be isolated. Using genomic and in vitro comparison, this study sought to characterize C. innocuum in the healthy human gut. Our analyses suggest that C. innocuum is a highly prevalent and diverse species, demonstrating clade-specific differences in metabolism and potential virulence. Collectively, this study is the first investigation into a broader description of C. innocuum as a human gut inhabitant.
Collapse
Affiliation(s)
- Disha Bhattacharjee
- Department of Biological Sciences, Clemson University, Clemson, South Carolina, USA
| | - Clara Flores
- Department of Biological Sciences, Clemson University, Clemson, South Carolina, USA
| | | | - Anna M. Seekatz
- Department of Biological Sciences, Clemson University, Clemson, South Carolina, USA
| |
Collapse
|
2
|
Cherny KE, Muscat EB, Reyna ME, Kociolek LK. Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen. Anaerobe 2021; 71:102418. [PMID: 34332070 DOI: 10.1016/j.anaerobe.2021.102418] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 07/19/2021] [Accepted: 07/21/2021] [Indexed: 10/20/2022]
Abstract
Clostridium innocuum is an anaerobic, gram-positive, spore-forming bacterium identified by Smith and King in 1962 after being isolated from a patient with an appendiceal abscess. Its name, C. innocuum, reflected its clinically "innocuous" nature based on observed lack of virulence in animal models of infection. Since that time, C. innocuum has been identified as both part of the normal intestinal flora and the cause of a rare, intrinsically vancomycin-resistant opportunistic infection in immunocompromised patients. More recently, reports from Taiwan suggest that C. innocuum, in addition to being a known extraintestinal pathogen, may also be a diarrheal pathogen that causes a C. difficile infection-like antibiotic-associated diarrheal illness. However, unanswered questions about the clinical relevance of C. innocuum remain. Here we review the microbiological and clinical characteristics of this emerging pathogen.
Collapse
Affiliation(s)
- Kathryn E Cherny
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
| | - Emily B Muscat
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | - Megan E Reyna
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | - Larry K Kociolek
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| |
Collapse
|
3
|
Wutzke KD, Tisztl M, Salewski B, Glass Ä. Dietary fibre-rich resistant starches promote ammonia detoxification in the human colon as measured by lactose-[¹⁵N₂]ureide. ISOTOPES IN ENVIRONMENTAL AND HEALTH STUDIES 2015; 51:488-96. [PMID: 26499512 DOI: 10.1080/10256016.2015.1092967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Three resistant starches (RSs), namely fibre of potatoes (FP), wrinkle pea starch (WPS), and high amylose maize starch (HAMS) with different dietary fibre contents, were supplemented in adults to evaluate their effects on urinary nitrogen and ammonia excretion as well as on faecal nitrogen excretion by means of lactose-[(15)N2]ureide ((15)N-LU) degradation. Twenty subjects received a regular diet either without or with the supplementation of FP, WPS, and HAMS in a randomized order. After administration of (15)N-LU, urine and faeces were collected over 48 and 72 h, respectively, whereas blood was collected after 6 h. The (15)N-abundances were measured by isotope ratio mass spectrometry. In comparison to the dry run, supplementation with RS significantly lowered renal (15)N-excretion (dry run: 43.2%, FP: 34.6%, WPS: 37.9%, HAMS: 36.4%) as well as the corresponding (15)NH3-excretion (dry run: 0.08%, FP: 0.06%, HAMS: 0.05%), clearly indicating a reduced colonic nitrogen generation at high dietary fibre intake.
Collapse
Affiliation(s)
- Klaus D Wutzke
- a Research Laboratory, Children's Hospital , University of Rostock , Rostock , Germany
| | - Michael Tisztl
- a Research Laboratory, Children's Hospital , University of Rostock , Rostock , Germany
| | - Birgit Salewski
- a Research Laboratory, Children's Hospital , University of Rostock , Rostock , Germany
| | - Änne Glass
- b Institute for Biostatistics and Informatics in Medicine and Ageing Research, University of Rostock , Rostock , Germany
| |
Collapse
|
4
|
Wutzke KD, Scholübbers D. The metabolic effect of resistant starch and yoghurt on the renal and faecal nitrogen and ammonia excretion in humans as measured by lactose-[(15)N2]ureide. ISOTOPES IN ENVIRONMENTAL AND HEALTH STUDIES 2013; 49:464-470. [PMID: 23937067 DOI: 10.1080/10256016.2013.804519] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Resistant starch (RS) and Lactobacillus acidophilus yoghurt (LC1) were supplemented simultaneously in healthy adults to evaluate the effect on the urinary and faecal nitrogen and ammonia excretion by means of lactose-[(15)N2]ureide ((15)N-LU) degradation. Nineteen subjects received a regular daily diet either without or with supplementation of an RS-LC1-mixture composed of fibre of potatoes (RS type 1), wrinkle pea starch (RS type 2), and LC1 over a 20-day period in randomised order. Thereafter, (15)N-LU was administered together with breakfast. Urine and faeces were collected over a period of 48 and 72 h, respectively. The (15)N abundances were measured by isotope ratio mass spectrometry. The intake of the pre- and probiotic mixture composed of RS of type 1, type 2 and of LC1 significantly lowered the colonic generation and the renal excretion of toxic (15)NH3 and functioned as an ammonia shift from urinary to faecal (15)N excretion when using (15)N-LU as a xenobiotic marker.
Collapse
Affiliation(s)
- Klaus D Wutzke
- a Research Laboratory, Children's Hospital , University of Rostock , Rostock , Germany
| | | |
Collapse
|
5
|
Sutton DGM, Preston T, Love S. In vitro validation of the lactose 13C-ureide breath test for equine orocaecal transit time measurement. Equine Vet J 2011:42-8. [PMID: 21790753 DOI: 10.1111/j.2042-3306.2011.00406.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
REASONS FOR PERFORMING STUDY Validation of a reliable, noninvasive clinical test for quantification of equine orocaecal transit time (OCTT) is required. This would facilitate an evidence-based approach to investigation and treatment of equine small intestinal disorders. OBJECTIVES 1) Comparison of the lactose (13) C-ureide breath test (LUBT) with the hydrogen breath test (H(2) BT) for OCTT measurement. 2) Identification of the characteristics of gastrointestinal microbial glycosylureide hydrolase activity in vitro. 3) Production of an optimised protocol for the LUBT for in vivo measurement of equine OCTT. HYPOTHESIS Significant lactose (13) C-ureide ((13) C-LU) hydrolase activity is restricted to the large bowel. The rate of expiratory (13) CO(2) production after ingestion of the isotope will provide an indirect quantifiable measure of orocaecal transit rate. Requisite bacterial activity may be enhanced by a primer dose of unlabelled substrate as shown in Man. METHODS Combined LUBT and H(2) BT were performed in 8 healthy individuals. Analysis of sequential end expiratory breath samples was used to calculate OCTT and results compared. Digestion of (13) C-LU was investigated in vitro using fresh faecal material or intestinal aliquots collected post mortem. Isotopic fermentation rate was measured by rate of appearance of (13) CO(2) . RESULTS Peaks in expiratory (13) CO(2) occurred in all individuals after ingestion of the labelled test meal, whereas H(2) expiration was variable. Both faecal and intestinal microbial digestion of (13) C-LU were maximised by prior exposure to (12) C-LU. Induced bacterial glucoseureide hydrolase activity was significantly greater in the caecum than in the small intestine (n = 10, P<0.05). CONCLUSIONS Significant (13) C-LU digestion is restricted to the equine large intestine under normal conditions, and is enhanced by prior exposure to (12) C-LU, making (13) C-LU a suitable noninvasive marker of equine OCTT. The LUBT is more reliable than the H(2) BT for measurement of equine OCTT.
Collapse
Affiliation(s)
- D G M Sutton
- School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK.
| | | | | |
Collapse
|
6
|
Sutton DGM, Preston T, Love S. Application of the lactose 13C-ureide breath test for measurement of equine orocaecal transit time. Equine Vet J 2011:49-55. [PMID: 21790754 DOI: 10.1111/j.2042-3306.2011.00407.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
REASONS FOR PERFORMING STUDY Application of the lactose (13) C-ureide breath test (LUBT) for measurement of equine orocaecal transit time (OCTT) has not been reported previously. The ability to assess OCTT noninvasively, and to investigate its relationship to gastric emptying rate and small intestinal transit, would be of both clinical and research value. OBJECTIVES 1) Assessment of the LUBT in healthy horses, with comparison of induced versus noninduced test protocols. 2) Application of a new dual stable isotope breath test (lactose (13) C-ureide and (13) C-octanoic acid) for gastrointestinal transit measurement. HYPOTHESIS The LUBT will allow quantification of equine OCTT, and test efficacy will be enhanced by prior administration of lactose (12) C-ureide as shown in vitro. The dual tracer breath test will permit simultaneous measurement of gastric emptying, OCTT and small bowel transit times. METHODS Induced and noninduced LUBTs were performed in 3 healthy mature horses in randomised order using a standard test meal and protocol. Combined LUBT and (13) C-octanoic acid breath tests ((13) C-OABT) were performed in 4 individuals on 4 occasions at weekly intervals. Expiratory isotopic recovery was modelled to allow generation of gastric emptying data, small bowel transit times and caecal transit parameters. RESULTS The induction protocol for the LUBT increased the rate and magnitude of expiratory (13) CO(2) significantly. Mean ± s.d. values for OCTT, caecal lag phase (t(lag) ) and caecal t(1/2) using the induced LUBT were 3.24 ± 0.65 h, 5.62 ± 1.22 h and 6.31 ± 1.21 h, respectively. Dual stable isotope tests resulted in the production of 2 discrete peaks in expiratory (13) CO(2) in 15/16 tests from which gastric t(1/2), OCTT and small bowel transit (SBT) parameters could be calculated. CONCLUSIONS The induced LUBT provides a reliable noninvasive measure of equine OCTT and can be paired with the (13) C-OABT to provide further information about small intestinal motility.
Collapse
Affiliation(s)
- D G M Sutton
- School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK.
| | | | | |
Collapse
|
7
|
Wutzke KD, Lotz M, Zipprich C. The effect of pre- and probiotics on the colonic ammonia metabolism in humans as measured by lactose-[¹⁵N₂]ureide. Eur J Clin Nutr 2010; 64:1215-21. [PMID: 20683456 DOI: 10.1038/ejcn.2010.120] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2009] [Revised: 05/05/2010] [Accepted: 05/18/2010] [Indexed: 11/09/2022]
Abstract
BACKGROUND The evaluation of ammonia detoxification by pre- and probiotics by means of colonic lactose-[(15)N(2)]ureide ((15)N-LU) degradation is of great interest both scientifically and in terms of nutrition physiology. OBJECTIVE Pre- and probiotics were supplemented in healthy adults to evaluate the effect of the ammonia metabolism in the human colon by means of (15)N-LU. METHODS A total of 14 participants aged 20-28 years daily received a regular diet either without (no treatment) or with supplementation of 30 g fibre of potatoes (FPs), 30 g wrinkle pea starch (WPS, resistant starch content: 12 and 70%, respectively) and 375 g Lactobacillus acidophilus (LC1) yoghurt, over a 10-day period in a randomised order. After 1 week, 5.7 mg/kg body weight (15)N-LU was administered together with breakfast. A venous blood sample was taken after 6 h. Urine and faeces were collected over a period of 48 and 72 h, respectively. The (15)N abundances were measured by isotope ratio mass spectrometry. RESULTS The mean renal (15)N-excretion differed significantly between the supplementation of FP and no treatment (32.5 versus 46.3%, P=0.034), FP and LC1 (32.5 versus 51.6%, P=0.001), and WPS and LC1 (38.5 versus 51.6%, P=0.048). The mean faecal (15)N-excretion amounted to 42.7% (no treatment), 59.7% (FP), 41.8% (WPS) and 44.0% (LC1). In comparison with no treatment, the urinary (15)NH(3)-enrichment was significantly decreased at 16 h after FP supplementation. CONCLUSION The prebiotic intake of FP and WPS lowered the colonic generation and the renal excretion of toxic (15)NH(3), respectively, when using (15)N-LU as a xenobiotic marker.
Collapse
Affiliation(s)
- K D Wutzke
- Research Laboratory Gastroenterology and Nutrition, Children's Hospital, University of Rostock, Rostock, Germany.
| | | | | |
Collapse
|
8
|
Wutzke KD, Mix J. The metabolic fate of doubly labelled lactose-[13C, 15N]ureide after pre-dosing with different ureides. Eur J Clin Nutr 2010; 64:733-8. [DOI: 10.1038/ejcn.2010.84] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
9
|
Berthold HK, Schober P, Scheurlen C, Marklein G, Horré R, Gouni-Berthold I, Sauerbruch T. Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test. J Gastroenterol 2010; 44:944-51. [PMID: 19551459 DOI: 10.1007/s00535-009-0097-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/13/2009] [Accepted: 06/04/2009] [Indexed: 02/04/2023]
Abstract
PURPOSE The glucose hydrogen breath test (GHBT) is commonly used as a noninvasive test to diagnose small bowel bacterial overgrowth (SBBO) but its validity has been questioned. Our aim was to evaluate the lactose-[(13)C]ureide breath test (LUBT) to diagnose SBBO and to compare it with the GHBT, using cultures of intestinal aspirates as a gold standard. METHODS In 22 patients with suspected SBBO (14 male, age range 18-73 years) aspirates were taken from the region of the ligament of Treitz under sterile conditions and cultured for bacterial growth. More than 10(6) colony-forming units/mL fluid or the presence of colonic flora was defined as culture positive (c+). After oral intake of 50 g glucose and 2 g of lactose-[(13)C]ureide, end-expiratory breath samples were obtained up to 120 min. The (13)C/(12)C ratio in breath CO(2) was determined by isotope ratio-mass spectrometry and hydrogen concentration in breath was analyzed electrochemically. RESULTS After analyzing receiver operating characteristic curves of the LUBT results, total label recovery of >0.88% at 120 min was considered positive. The test had a sensitivity of 66.7% and a specificity of 100% to predict c+. In the GHBT, an increase of the signal of > or =12 ppm from baseline was considered positive. The sensitivity and specificity of the test were 41.7 and 44.4%, respectively. CONCLUSIONS The new stable isotope-labeled LUBT has excellent specificity but suboptimal sensitivity. In contrast, the standard GHBT lacks both high sensitivity and specificity. The LUBT is superior to the GHBT for detecting SBBO.
Collapse
Affiliation(s)
- Heiner K Berthold
- Department of Clinical Pharmacology, University of Bonn, Bonn, Germany.
| | | | | | | | | | | | | |
Collapse
|
10
|
Breath tests in pediatrics. Clin Chim Acta 2008; 397:1-12. [DOI: 10.1016/j.cca.2008.07.023] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2008] [Revised: 07/22/2008] [Accepted: 07/22/2008] [Indexed: 12/19/2022]
|
11
|
De Preter V, Geboes K, Verbrugghe K, De Vuyst L, Vanhoutte T, Huys G, Swings J, Pot B, Verbeke K. The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. Br J Nutr 2007; 92:439-46. [PMID: 15469647 DOI: 10.1079/bjn20041228] [Citation(s) in RCA: 72] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Amongst the various claimed beneficial effects of pro- and prebiotics for the human host, it has been hypothesised that functional foods are able to suppress the generation and accumulation of toxic fermentation metabolites (NH3, p-cresol). Direct evidence supporting this hypothesis is lacking mainly because of the unavailability of reliable biomarkers. Preliminary data indicate that lactose-[15N]ureide and [2H4]tyrosine may be potential biomarker candidates. The aim of the present study was to evaluate the effect of pro- and prebiotics on the colonic fate of these biomarkers in a randomised, placebo-controlled, cross-over study with nineteen healthy volunteers. At the start of the study and at the end of each 2-week study period, during which they were administered either a probiotic (n 10; 6·5×109Lactobacillus casei Shirota cells twice daily) or a prebiotic (n 9; lactulose 10 g twice daily), the volunteers consumed a test meal containing the two biomarkers. Urine was collected during 48 h. Results were expressed as percentage of the administered dose. As compared with the placebo, the decrease in the percentage dose of p-[2H4]cresol in the 24–48 h urine fraction was significantly higher after probiotic intake (P=0·042). Similar changes were observed for the 15N tracer (P=0·016). After prebiotic intake, a significantly higher decrease in the percentage dose of p-[2H4]cresol (P=0·005) and 15N tracer (P=0·029) was found in the 0–24 h urine collection. The present results demonstrate that suppression of the generation and accumulation of potentially toxic fermentation metabolites by pro- and prebiotics can reliably be monitored in vivo by the use of stable isotope-labelled biomarkers.
Collapse
Affiliation(s)
- V De Preter
- Department of Gastrointestinal Research, University Hospital Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Wutzke KD, Schütt M. The duration of enzyme induction in orocaecal transit time measurements. Eur J Clin Nutr 2007; 61:1162-6. [PMID: 17268412 DOI: 10.1038/sj.ejcn.1602633] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE In this study, the duration of enzyme induction provoked by unlabelled lactose ureide (LU) in orocaecal transit time (OCTT) measurements with lactose-[(13)C]ureide ((13)C-LU) was evaluated. DESIGN Experimental study. SETTING University of Rostock, Children's Hospital, Research Laboratory. SUBJECTS Fifteen healthy adults aged 19-54 years. INTERVENTION One-half gram of (13)C-LU was administered together with a continental breakfast. After 1 week, the test was repeated after pre-dosing of 5 x 100 mg LU on the day before the study began. The (13)C-LU ingestion was repeated under identical conditions but without pre-dosing 1 and 3 weeks after pre-dosing. Expired air samples were taken over 14 h. (13)CO(2)-enrichment was measured by isotope ratio mass spectrometry (SerCon, Crewe, UK). The OCTT was calculated from the interval between (13)C-LU administration and the detection of a significant and sustained (13)C-rise of 2 delta over baseline in breath. RESULTS Without pre-dosing, an OCTT of 419+/-82 min was measured. The pre-dosing resulted in higher (13)C-enrichments and caused a significant OCTT shortening of 311+/-99 min (P=0.028). One and 3 weeks after pre-dosing, the measured OCTT again increased to 404+/-124 and 379+/-103 min, respectively. CONCLUSIONS Pre-dosing with LU before pulse labelling with (13)C-LU led to an induction of enzyme activity and resulted in a definitive estimation of the OCTT when using a threshold of 2 delta over baseline. After 1 and 3 weeks, respectively, the OCTT was no longer significantly different to those without pre-dosing, indicating the disappearance of enzyme induction. Therefore, a pre-dosing with LU on the day before (13)C-LU ingestion is essential for OCTT measurements.
Collapse
Affiliation(s)
- K D Wutzke
- 1Research Laboratory Gastroenterology and Nutrition, Children's Hospital, University of Rostock, Rostock, Germany.
| | | |
Collapse
|
13
|
De Preter V, Verbeke K. Evaluation of the necessity of induction for lactose-[15N, 15N]-ureide to study the colonic ammonia metabolism. Scand J Gastroenterol 2006; 41:396-400. [PMID: 16635906 DOI: 10.1080/00365520500279688] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE Stable isotope labelled glycosyl ureides have been described as non-invasive markers for measurement of gastrointestinal processes. Lactose-[13C]-ureide is used for the evaluation of orocaecal transit time (OCTT), whereas lactose-[15N, 15N]-ureide is used to study the fate of the NH3 metabolism in the colon. Induction with unlabelled lactose ureide is necessary for the determination of the OCTT. In the present study, the effect of a preceding induction on the fate of 15NH3 in the colon was evaluated. MATERIAL AND METHODS Ten healthy volunteers performed two tests: the first test without induction, the second test one week later with induction, i.e. administration of 1 g lactose ureide the evening before the test. Each test consisted of a fractionated 24-h urine collection after the subjects had received a pancake test meal labelled with 75 mg lactose-[15N, 15N]-ureide. All samples were analysed for [15N]-content by combustion IRMS (isotope ratio mass spectrometry) and results were expressed as a percentage of the administered dose. RESULTS No significant differences were found in the percentage dose 15N excreted in the different urine fractions between the test without and with preceding induction. The cumulative excretion rates of the 15N-isotope after 24 h were 44.35% without induction and 44.27% with induction. CONCLUSIONS The results in this study show that predosing with unlabelled lactose ureide is unnecessary for the evaluation of the ammonia metabolism in the colon by means of lactose-[15N, 15N]-ureide.
Collapse
Affiliation(s)
- Vicky De Preter
- Department of Gastrointestinal Research, University Hospital Gasthuisberg, K.U. Leuven, Leuven, Belgium
| | | |
Collapse
|
14
|
De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther 2006; 23:963-74. [PMID: 16573799 DOI: 10.1111/j.1365-2036.2006.02834.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/08/2022]
Abstract
BACKGROUND Protein fermentation products, especially ammonia, are implicated in the pathogenesis of certain diseases. AIM To investigate the influence of lactulose and Saccharomyces boulardii cells on the composition of the intestinal microbiota and on the metabolic fate of ammonia by means of lactose-[(15)N, (15)N]-ureide. METHODS An at random, placebo-controlled, crossover study was performed in 43 healthy volunteers to evaluate the influence of lactulose and/or S. boulardii cells either administered as a single dose or after a 4-week intake period. Urine and faeces were collected. All samples were analysed for (15)N-content by combustion-isotope ratio mass spectrometry. Real-time polymerase chain reaction was applied to determine the composition of the predominant faecal microbiota. RESULTS A single administration of lactulose significantly decreased urinary (15)N-excretion in a dose-dependent way. After long-term administration of lactulose, a significant reduction of the urinary (15)N-excretion was observed, which was accompanied with a significant increase in the faecal (15)N-output, more specifically more (15)N was found in the bacterial fraction. A significant rise in the Bifidobacterium population was found after lactulose intake. No significant effects were observed after S. boulardii intake. CONCLUSION Dietary addition of lactulose can exert a bifidogenic effect accompanied by a favourable effect on the colonic NH(3)-metabolism.
Collapse
Affiliation(s)
- V De Preter
- Department of Gastrointestinal Research, University Hospital Gasthuisberg, KU Leuven, Belgium
| | | | | | | | | | | |
Collapse
|
15
|
Priebe MG, Wachters-Hagedoorn RE, Landman K, Heimweg J, Elzinga H, Vonk RJ. Influence of a subsequent meal on the oro-cecal transit time of a solid test meal. Eur J Clin Invest 2006; 36:123-6. [PMID: 16436094 DOI: 10.1111/j.1365-2362.2006.01601.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Oro-cecal transit time (OCTT) is determined for clinical diagnostics of intestinal complaints and research purposes. Ingestion of a subsequent meal during the test period shortens the OCTT of a liquid test meal (glucose solution), as previously reported. This study was conducted to determine whether the same phenomenon occurs after ingestion of a solid test meal. MATERIALS AND METHODS The OCTT of a pancake was measured with the lactose-[(13)C]-ureide breath test on two occasions in 28 volunteers. All the volunteers took the same subsequent meal once at 4 h and at 6 h after ingestion of the pancake. RESULTS In 16 of the 56 tests no increase in breath-(13)CO(2) was observed. No statistically significant difference was found between the OCTTs of the test meal after ingestion of the subsequent meal at 4 h or 6 h (367; 311-405 min and 290; 370-405 min, median quartiles, respectively) (P = 0.14, n = 18). Only a subgroup (n = 4) with a short OCTT in the test with the 4-h subsequent meal (278; 259-296 min) tended to have a longer OCTT in the test with the 6-h subsequent meal (390; 379-401 min; P = 0.059). CONCLUSION The effect of the ingestion of a subsequent meal on the transit time of a test meal is shown to be dependent on the physical form and/or caloric content of the test meal.
Collapse
Affiliation(s)
- M G Priebe
- Laboratory of Nutritio and Metabolism, University of Groningen Medical Center, Groningen, the Netherlands.
| | | | | | | | | | | |
Collapse
|
16
|
Metges CC, Eberhard M, Petzke KJ. Synthesis and absorption of intestinal microbial lysine in humans and non-ruminant animals and impact on human estimated average requirement of dietary lysine. Curr Opin Clin Nutr Metab Care 2006; 9:37-41. [PMID: 16444817 DOI: 10.1097/01.mco.0000196142.72985.d3] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE OF REVIEW While there are reports on the nature of synthesis and absorption of intestinal microbial lysine in humans and non-ruminant animals, there are few efforts to quantify microbial amino acid absorption in human subjects. We review the available information on the synthesis of microbial lysine and the quantification of its absorption and utilization by the human host and monogastric model animals. In addition, we explore the impact of microbial lysine on the current estimated average requirement of dietary lysine. RECENT FINDINGS It is still uncertain whether microbial amino acids are absorbed primarily from the small or the large intestine in humans. In the pig, the majority of microbial lysine is absorbed in the small intestine. It appears that microbial lysine contribution is responsive to the nutritional status of the host. Estimates for microbial lysine contribution in adult humans on adequate or low protein diets range from 12 to 68 mg/kg per day. It is unlikely that these estimates represent net values because of methodological concerns related to the 15N tracer methodology used. SUMMARY We conclude that microbial lysine contributes to the lysine homeostasis in humans and other non-ruminant mammals. Microbial lysine utilization by the host is a continuous process and occurs both with low, adequate, and high protein intakes, and under protein-free and low lysine dietary conditions in growing and adult individuals. We also conclude that the estimated average lysine requirement for humans already considers lysine contributed by the intestinal microbiota.
Collapse
Affiliation(s)
- Cornelia C Metges
- Research Institute for the Biology of Farm Animals (FBN), Research Unit Nutritional Physiology, 18196 Dummerstorf, Germany.
| | | | | |
Collapse
|
17
|
Priebe MG, Wachters-Hagedoorn RE, Stellaard F, Heiner AM, Elzinga H, Vonk RJ. Oro-cecal transit time: influence of a subsequent meal. Eur J Clin Invest 2004; 34:417-21. [PMID: 15200493 DOI: 10.1111/j.1365-2362.2004.01357.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND Small intestinal and oro-cecal transit time (OCTT) is determined for clinical diagnostics and research purposes. Experimental protocols used vary with respect to the inclusion of a subsequent meal during the test period. This study was conducted to elucidate whether the ingestion of a subsequent meal during the test period influences the OCTT of the test meal. MATERIALS AND METHODS The OCTT of a liquid test meal, measured with the lactose-[(13)C]ureide breath test, was compared between four groups of healthy volunteers (n = 36) who consumed the subsequent meal at different time points. Also, the OCTT was determined twice in eight subjects; a subsequent meal was ingested after 180 min (test A) and after 360 min (test B). RESULTS An apparently meal-related increase in median OCTT was observed. The OCTT of the eight volunteers measured in test A (210; 210-349 median; quartiles) was significantly shorter than that found in test B (345; 300-375 min, P = 0.016). As result of the ingestion of the subsequent meal at 180 min the OCTT was shortened by 90; 64-116 min in 7/8 subjects. CONCLUSION These data indicate that the ingestion of a subsequent meal affects the OCTT of a liquid test meal. This phenomenon could be explained by the increased intestinal motility in response to a meal, and should be taken into account when designing protocols for measurements of the OCTT and in the interpretation of small intestinal absorption studies.
Collapse
Affiliation(s)
- M G Priebe
- Department of Pediatrics, University of Groningen, Groningen, The Netherlands.
| | | | | | | | | | | |
Collapse
|
18
|
Wutzke KD, Glasenapp B. The use of 13C-labelled glycosyl ureides for evaluation of orocaecal transit time. Eur J Clin Nutr 2004; 58:568-72. [PMID: 15042123 DOI: 10.1038/sj.ejcn.1601846] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE In the present study, cellobiose-[13C]ureide and glucose-[13C]ureide were synthesized and tested as alternative substrates for noninvasive evaluation of the orocaecal transit time (OCTT). DESIGN Experimental study. INTERVENTION In total, 1 g cellobiose-[13C]ureide was administered together with a continental breakfast either without or after predosing of 5 x 1 g unlabelled cellobiose ureide on the day prior to study commencement. After 2 weeks, the same subjects ingested glucose-[13C]ureide (dosage: 0.57 g) either without or after predosing of the respective unlabelled ureide under identical conditions. Expired air samples were taken over 10 h. 13CO2-enrichment was measured by isotope ratio mass spectrometry (PDZ Europa, Sandbach, UK). The OCTT was calculated from the interval between 13C-ureide administration and the detection of a significant and sustained 13C-rise of 2 delta over baseline in breath. SETTING University of Rostock, Children's Hospital, Research Laboratory. SUBJECTS Eight healthy adults aged 22-55 y. RESULTS After application of cellobiose-[13C]ureide and glucose-[13C]ureide OCTTs of 401 and 415 min, respectively, were measured. The predosing resulted in higher and steeper 13C-enrichments and caused a significant shortening of OCTTs of 265 and 287 min, respectively (P=0.012 and 0.017). CONCLUSIONS The onset of 13CO2-enrichment reflected the degradation of glycosyl-[13C]ureides by glucose ureide hydrolase. The predosing with unlabelled ureides prior to pulse labelling with cellobiose-[13C]ureide and glucose-[13C]ureide (the latter is the key substance of the enzymatic sugar-ureide degradation) led to an induction of enzyme activity and resulted in a more precise and similar estimation of the OCTT when using both 13C-labelled ureides.
Collapse
Affiliation(s)
- K D Wutzke
- Children's Hospital, Research Laboratory, University of Rostock, Rostock, Germany.
| | | |
Collapse
|
19
|
Morrison DJ, Dodson B, Preston T, Weaver LT. Gastrointestinal handling of glycosyl [13C]ureides. Eur J Clin Nutr 2003; 57:1017-24. [PMID: 12879097 DOI: 10.1038/sj.ejcn.1601637] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVES Lactose [(13)C]ureide has been proposed as a noninvasive marker for oro-caecal transit time in adults and children. The present study investigates the handling of lactose [(13)C]ureide ((13)C LU) and glucose [(13)C]ureide ((13)C GU) by the gastrointestinal tract and describes the metabolic fates of these substrates and describes the extent of tracer excretion by different routes. STUDY DESIGN AND SUBJECTS Four subjects underwent five studies in which they ingested a test meal plus (1) no substrate, (2) (13)C LU, (3) (13)C GU, (4) (13)C LU after predosing with unlabelled lactose ureide and (5) (13)C LU after predosing with glucose ureide. Subjects were studied at home with at least 1 week between tests and they all completed the study. Breath was analysed for (13)CO(2) recovery and urine was analysed for total (13)C recovery, (13)C urea recovery and (13)C GU recovery. RESULTS The profiles and extent of tracer recovery in breath and urine were similar when either (13)C GU or (13)C LU was used, suggesting similar handling of these substrates by the gut. (13)C GU was the major (13)C-enriched species recovered in the urine even when (13)C LU was consumed. Predosing with either lactose ureide or glucose ureide increased the rate of appearance of tracer, but did not alter transit times. CONCLUSIONS (13)C LU is hydrolysed to (13)C GU in the small intestine with the fraction of (13)C GU appearing in the urine probably limited by small intestinal permeability. Either (13)C LU or (13)C GU can be used to measure oro-caecal transit time.
Collapse
Affiliation(s)
- D J Morrison
- Department of Child Health, University of Glasgow, Yorkhill Hospitals, Glasgow, G3 8SJ UK.
| | | | | | | |
Collapse
|
20
|
Hamafuji T, Tsugawa W, Sode K. Clinical application of the serum 1,5-anhydroglucitol assay method using glucose 3-dehydrogenase. J Clin Lab Anal 2002; 16:299-303. [PMID: 12424803 PMCID: PMC6807711 DOI: 10.1002/jcla.10054] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
We attempted to develop a novel serum 1,5-anhydroglucitol (1,5-AG) assay kit using glucose 3-dehydrogenase (G3DH) from Halomonas sp. alpha-15 strain. The major advantages of this method are that the 1,5-AG detection requires a very small amount of G3DH, and the enzyme catalyzes a simple reaction. The analytical performances were acceptable for clinical use operated with a clinical automatic analyzer. The correlation with a commercial assay kit against sera of healthy volunteers was y=0.975x+0.008, r=0.993, Sylx=1.32 microg/mL. However, sham-negative specimens were observed in the validation of this method using specimens from hospital patients.
Collapse
Affiliation(s)
- Tetsuro Hamafuji
- Department of Biotechnology, Faculty of Technology, Tokyo University of Agriculture and Technology, Tokyo, Japan.
| | | | | |
Collapse
|
21
|
Christian M, Morrison D, Dodson B, Preston T, Amarri S, Franchini F, Edwards C, Weaver L. Measurement of oro-cecal transit time in young children using lactose [13C] ureide requires further validation. J Pediatr Gastroenterol Nutr 2002; 34:570-1; author reply 571. [PMID: 12050590 DOI: 10.1097/00005176-200205000-00024] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
|
22
|
Morrison DJ, Dodson B, Preston T, Weaver LT. Rapid quality control analysis of (13)C-enriched substrate synthesis by isotope ratio mass spectrometry. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2001; 15:1279-1282. [PMID: 11466784 DOI: 10.1002/rcm.341] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
There is a growing interest in the use of (13)C-enriched substrates to investigate metabolic processes in humans. The non-invasive nature of (13)C breath tests makes them attractive to clinicians, particularly because they can be safely used in children. The availability of suitable (13)C-enriched substrates can limit the application of this biotechnology. We have used isotope ratio mass spectrometry to assay the chemical purity and isotopic enrichment of substrates that were synthesised to study gut transit and colonic fermentation. Lactose ureide and lactose [(13)C]ureide were synthesised by acid-catalysed condensation of lactose and urea or (13)C urea, respectively. Glucose ureide and glucose [(13)C]ureide were synthesised by similar methods but required an additional purification step to remove urea of crystallisation. Substrates were analysed by standard analytical techniques and combustion isotope ratio mass spectrometry for carbon and nitrogen content and (13)C-enrichment. Monitoring the C/N ratio proved to be a sensitive assay of chemical purity. Analysis of the percentage composition of C and N (and hence O + H) suggested that lactose ureide crystallises as the dihydrate. It was synthesised with approximately 99% chemical purity and with the theoretical enrichment. Glucose ureide was synthesised with approximately 98% chemical purity but with lower than theoretical enrichment.
Collapse
Affiliation(s)
- D J Morrison
- Department of Child Health, University of Glasgow, Yorkhill Hospitals, Glasgow G3 8SJ, Scotland, UK.
| | | | | | | |
Collapse
|
23
|
Van Den Driessche M, Van Malderen N, Geypens B, Ghoos Y, Veereman-Wauters G. Lactose-[13C]ureide breath test: a new, noninvasive technique to determine orocecal transit time in children. J Pediatr Gastroenterol Nutr 2000; 31:433-8. [PMID: 11045843 DOI: 10.1097/00005176-200010000-00019] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
BACKGROUND The lactose-[13C]ureide breath test (LUBT) is a novel, noninvasive test to determine orocecal transit time. Lactose ureide resists the action of brush border enzymes and is metabolized by colonic bacteria. The purpose of the present study was to adapt this breath test for children of various age groups and to determine whether it can be applied in infants, newborns, and preterms to study the development of small intestinal motility. METHODS In a group of 20 children (3-17 years) in vitro stool analysis and in vivo LUBT results were compared. From each subject a blank stool sample and a sample produced after induction with unlabeled lactose ureide were incubated with 10 mg lactose-[13C]ureide in small, closed bottles. Ten-milliliter CO2 samples were aspirated from the bottles using a needle and a syringe every 30 minutes for 24 hours. All children performed the breath test after induction of 500 mg unlabeled lactose ureide three times the prior day. A liquid test meal (chocolate milk) with 250 mg lactose-[13C]ureide was ingested. Breath samples were collected every 15 minutes for 10 hours. In a second group of 32 children (age range, 0-3 years) consisting of 6 children between 1 and 3 years of age, 6 infants between 6 and 12 months, 13 infants between 0 and 6 months, and 7 preterm infants, only the in vitro stool analysis was performed. Stools were collected for stool incubation, as described. RESULTS The mean orocecal transit time in the group of 20 children aged 3 to 17 years was 255 minutes (range, 165-390 minutes). Stool incubations demonstrated a clear 13CO2 peak in all infants aged more than 8 months, indicating that their colonic bacterial enzymic activity hydrolyses lactose ureide. However, in all infants aged less than 6 months and in preterm infants, the 13CO2 signal was absent, indicating that those subjects were unable to hydrolyze lactose ureide. CONCLUSION Infants aged less than 6 months do not host the appropriate bacterial enzymic activity for splitting lactose ureide. The authors conclude that the LUBT can be applied in infants aged more than 8 months, after weaning to solid foods, to determine orocecal transit time.
Collapse
|